Scharf Investments, LLC Abbott Laboratories Transaction History

Scharf Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 13, 2022	SELL	$114.02 - $139.04 $651,510 - $794,474	-5,714 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$115.53 - $141.46 $7,393 - $9,053	64 Added 1.13%	5,714 $804,000
Q3 2021 Oct 14, 2021	BUY	$116.66 - $129.06 $115,843 - $128,156	993 Added 21.32%	5,650 $667,000
Q2 2021 Jul 16, 2021	BUY	$105.79 - $124.53 $127,476 - $150,058	1,205 Added 34.91%	4,657 $540,000
Q1 2021 Apr 14, 2021	BUY	$108.84 - $128.23 $171,531 - $202,090	1,576 Added 84.01%	3,452 $414,000
Q4 2020 Jan 20, 2021	BUY	$105.0 - $114.42 $196,980 - $214,651	1,876 New	1,876 $205,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Scharf Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Scharf Investments, LLC with notifications on news.